medigraphic.com
ISSN 1527-3172 (Digital)

2022, Número 3-4

<< Anterior Siguiente >>

MEDICC Review 2022; 24 (3-4)


Epidemiological Characterization of Patients in the First Eight Weeks Following Detection of SARS-CoV-2 B.1.1.529 (omicron) Variant in Cuba

Pérez-Santos L, Kourí-Cardellá V, Tejero-Suárez Y, Macías-Roig LM, Pintos-Saavedra Y, Medero-Díaz D, Figueredo-Amador C, Naranjo-González C, Morales-Arredondo D, Tamayo-Pérez NE, Martínez-Montesino Y, López-Almaguer Y, de Armas-Fernández JR, Portal-Miranda JA, Guzmán-Tirado MG

Idioma: Ingles.
Referencias bibliográficas: 29
Paginas:
Archivo PDF: 403.64 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. World Health Organization [Internet]. Geneva:World Health Organization; c2022. Activities.Tracking SARS-CoV-2 variants; 2022 [updated 2022 Jul 7; cited 2022 Feb 26]; [about 5 p.].Available at: https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/

  2. World Health Organization [Internet]. Geneva:World Health Organization; c2022. News.Classifi cation of Omicron (B.1.1.529): SARSCoV-2 Variant of Concern; 2021 Nov 26 [cited2021 Dec 26]. Available at: www.who.int/news/item/26-11-2021-classification-of-omicron-%28b.1.1.529%29-sars-cov-2-variant-of-concern

  3. Fernandes Q, Inchakalody VP, Merhi M, MestiriS, Taib N, Moustafa Abo El-Ella D, et al. EmergingCOVID-19 variants and their impact onSARS-CoV-2 diagnosis, therapeutics and vaccines.Ann Med. 2022;54(1):524–40. https://doi.org/10.1080/07853890.2022.2031274

  4. Mohapatra RK, Tiwari R. Omicron (B.1.1.529)variant of SARS-CoV-2: concerns, challenges,and recent updates. J Med Virol. 2022Jun;94(6):2336–42. https://doi.org/10.1002/jmv.27633

  5. Rahimi F, Talebi Bezmin Abadi A. Omicron:a highly transmissible SARS-CoV-2 variant.Gene Rep. 2022 Jun;27:101549. https://doi.org/10.1016/j.genrep.2022.101549

  6. Sikora D, Rzymski P. COVID-19 vaccinationand rates of infections, hospitalizations,ICU admissions, and deaths in the Europeaneconomic area during autumn 2021 wave ofSARS-CoV-2. Vaccines (Basel). 2022 Mar12;10(3):437. https://doi.org/10.3390/vaccines10030437

  7. Bhattacharyya RP, Hanage WP. Challenges in inferringintrinsic severity of the SARS-CoV-2 Omicronvariant. N Engl J Med. 2022 Jun 17;386(7):e14.https://doi.org/10.1056/nejmp2119682

  8. World Health Organization [Internet]. Geneva:World Health Organization; c2022. Publications.Overview. Enhancing response to OmicronSARS-CoV-2 variant: technical brief and priorityactions for member states; 2022 Jan 21 [cited2022 Feb 20]. 28 p. Available at: https://www.who.int/publications/m/item/enhancing-readiness-for-omicron-%28b.1.1.529%29-technical-brief-and-priority-actions-for-member-states

  9. Ministry of Public Health (CU) [Internet]. Havana:Ministry of Public Health (CU); c2022. COVID-19.Variantes de SARS-CoV-2 en Cuba: motivo máspara fortalecer las medidas de aislamiento; 2021Apr 21 [cited 2022 Feb 23]; [about 4 p.]. Availableat: https://salud.msp.gob.cu/variantes-de-sars-cov-2-en-cuba-motivo-mas-para-fortalecer-las-medidas-de-aislamiento/. Spanish.

  10. Ministry of Public Health (CU) [Internet].Havana: Ministry of Public Health (CU); c2022.COVID-19. Noticias. Variante Delta: desafíose incertidumbres ante mayor incidencia deCOVID-19; 2021 Aug 16 [cited 2022 Feb 23]; [about 5p.]. Available at: https://salud.msp.gob.cu/variante-delta-desafios-e-incertidumbres-ante-mayor-incidencia-de-covid-19/. Spanish.

  11. Portal Miranda JA. Health intervention withvaccine candidates as a temporary strategy toconfront COVID-19, Cuba, 2021. Rev CubanaSalud Pública [Internet]. 2021 Jan 5 [cited 2022Feb 23];48(1):e3513. Available at: http://www.revsaludpublica.sld.cu/index.php/spu/article/view/3513. Spanish.

  12. Ministry of Public Health (CU) [Internet]. Havana:Ministry of Public Health (CU); c2022. Noticias.Nota informativa del Ministerio de Salud Pública.2021 Nov 29 [cited 2022 Feb 13]; [about 1p.]. Available at: https://salud.msp.gob.cu/nota-informativa-del-ministerio-de-salud-publica/.Spanish.

  13. Ministry of Public Health (CU) [Internet]. Havana:Ministry of Public Health (CU); c2022 Noticias.Ministro de Salud: Es imprescindible reforzarlas medidas para proteger el país; 2021 Dec30 [cited 2022 Feb 23]; [about 4 p.]. Availableat: https://salud.msp.gob.cu/es-imprescindible-reforzar-las-medidas-para-proteger-el-pais/.Spanish.

  14. Center for Disease Control and Prevention. Protocolsfor SARS-CoV-2 sequencing [Internet].California: Pacifi c Biosciences of California; 2020[cited 2022 Feb 23]. 7 p. Available at: https://www.pacb.com/wp-content/uploads/Customer-Collaboration-PacBio-Compatible-CDC-Protocols-for-SARS-CoV-2-Sequencing.pdf

  15. Global Initiative on Sharing All Infl uenza Data(GISAID) [Internet]. Munich: Global Initiative onSharing All Infl uenza Data (GISAID); c2008–2022. CoVsurver: Mutation Analysis of hCoV-19;2021 [cited 2022 Jan 20]. Available at: https://www.gisaid.org/epiflu-applications/covsurver-mutations-app/

  16. World Health Organizatioon [Internet]. Geneva:World Health Organization; c2022. Publications.Overview. Living guidance for clinical managementof COVID-19; 2021 Nov 23 [cited 2022Feb 23]; [2.4 MB]. Available at: https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-2

  17. Ministry of Public Health (CU) [Internet]. Havana:Ministry of Public Health (CU); c2022. Candidatosvacunales. Actualización de la estrategia parael desarrollo de las vacunas cubanas; [cited 2022Jul 29]; [about 6 p.]. Available at: https://salud.msp.gob.cu/actualizacion-de-la-vacunacion-en-el-marco-de-los-estudios-de-los-candidatos-vacunales-cubanos-y-la-intervencion-sanitaria/.Spanish

  18. Reported Cases and Deaths by Country orTerritory [Internet]. [place unknown]: Worldometers;2022 [cited 2022 March 7]; [about10 p.]. Available at: www.worldometers.info/coronavirus/#countries

  19. Ministry of Public Health (CU) [Internet]. Havana:Ministry of Public Health (CU); c2022. Noticias.Nota informativa del Ministerio de Salud Pública. 2021 Dec 15 [cited 2022 Feb 26]. Available at:https://salud.msp.gob.cu/nota-informativa-del-ministerio-de-salud-publica-3/. Spanish.

  20. CDC COVID-19. SARS-CoV-2 B.1.1.529 (Omicron)Variant - United States, December 1-8,2021. MMWR Morb Mortal Wkly Rep. 2021 Dec17;70(50):1731–4. https://doi.org/10.15585/mmwr.mm7050e1

  21. Network of Genomic Surveillance in South Africa(NGS-SA). SARS-CoV-2 Sequencing Update 26November 2021 [Internet]. Durban: Network ofGenomic Surveillance in South Africa (NGS-SA),Nelson R. Mandela School of Medicine; 2021[cited 2022 Feb 14]. 28 p. Available at: https://www.nicd.ac.za/wp-content/uploads/2021/11/Update-of-SA-sequencing-data-from-GISAID-26-Nov_Final.pdf

  22. Fall A, Eldesouki RE, Sachithanandham J, PaulMorris C, Norton JM, Gaston DC, et al. A quickdisplacement of the SARS-CoV-2 variant Deltawith Omicron: unprecedented spike in COVID-19cases associated with fewer admissions andcomparable upper respiratory viral loads. medRxiv[Preprint]. 2022 Jan 28. 2022.01.26.22269927.https://doi.org/10.1101/2022.01.26.22269927

  23. Mohapatra RK, Tiwari R. Twin combination ofOmicron and Delta variants triggering a tsunamiwave of ever high surges in COVID-19 cases:a challenging global threat with a special focuson the Indian subcontinent. J Med Virol. 2022May;94(5):1761–5. https://doi.org/10.1002/jmv.27585

  24. Ministry of Public Health (CU) [Internet]. Havana:Ministry of Public Health (CU); c2022. Candidatosvacunales. Actualización de la estrategia parael desarrollo de las vacunas cubanas; [cited 2022June 3]; [about 6 p.]. Available at: https://salud.msp.gob.cu/actualizacion-de-la-vacunacion-en-el-marco-de-los-estudios-de-los-candidatos-vacunales-cubanos-y-la-intervencion-sanitaria/.Spanish.

  25. Our World in Data [Internet]. Oxford: GlobalChange Data Lab; c2022. Coronavirus. Vaccinations.Coronavirus (COVID-19) Vaccinations;[cited 2022 May 30]; [about 10 p.]. Available at:https://ourworldindata.org/covid-vaccinations

  26. Garrett N, Tapley A, Andriesen J, Seocharan I,Fisher LH, Bunts L, et al. High rate of asymptomaticcarriage associated with variantstrain Omicron. medRxiv [Preprint]. 2022 Jan14;2021.12.20.21268130. https://doi.org/10.1101/2021.12.20.21268130

  27. Piersiala K, Kakabas L, Bruckova A, StarkhammarM, Cardell LO. Acute odynophagia - a newsymptom of COVID-19 during the SARS-CoV-2Omicron variant wave in Sweden. J Intern Med.2022 Jul;292(1):154–61. https://doi.org/10.1111/joim.13470

  28. Kahn F, Bonander C, Moghaddassi M, RasmussenM, Malmqvist U, Inghammar M, et al. Riskof severe COVID-19 from the Delta and Omicronvariants in relation to vaccination status, sex,age and comorbidities - surveillance results fromsouthern Sweden, July 2021 to January 2022.Euro Surveill. 2022 Mar;27(9):2200121. https://doi.org/10.2807/1560-7917.es.2022.27.9.2200121

  29. Vanshylla K, Tober-Lau P, Gruell H, Münn F,Eggeling R, Pfeifer N, et al. Durability of omicronneutralisingserum activity after mRNA boosterimmunisation in older adults. Lancet Infect Dis.2022 Apr;22(4):445–6. https://doi.org/10.1016/s1473-3099(22)00135-9




2020     |     www.medigraphic.com